NewsBenzingaMirion Technologies 将 2026 财年调整后每股收益指引从 0.48-0.55 美元下调至 0.50-0.54 美元,低于 0.54 美元预期;将 2026 财年销售额指引从 11.29 亿-11.47 亿美元上调至 11.47 亿-11.57 亿美元,高于 11.39 亿美元预期 Mirion Technologies 将 2026 财年调整后每股收益指引从 0.48-0.55 美元下调至 0.50-0.54 美元,低于 0.54 美元预期;将 2026 财年销售额指引从 11.29 亿-11.47 亿美元上调至 11.47 亿-11.57 亿美元,高于 11.39 亿美元预期 Benzinga 2026.10.27 20:16 (GMT+0) Open on Benzinga Other news Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage SpaceX, Meta and Nebius Stand to Benefit From Nvidia’s ‘Fastest Product Ramp’ Yet: Strategist Shay Boloor Explains Why Binance Plans to Expand into Five Asian Markets Next Year, Focusing on South and Southeast Asia Innate Pharma Reports IPH4502 Phase 1 Data Across 76 Patients: Maximum Tolerated Dose 3.6 Mg/Kg Q3W, Grade 3+ TEAEs In 43.4%, Stomatitis Only Dose-Limiting Toxicity Olema Reports Selective KAT6A Degraders Potently Inhibit Proliferation In Diverse ER+/HER2- Breast Cancer Models, Active In ESR1-Mutant And Wild-Type, Well-Tolerated
Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled
FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage
SpaceX, Meta and Nebius Stand to Benefit From Nvidia’s ‘Fastest Product Ramp’ Yet: Strategist Shay Boloor Explains Why
Innate Pharma Reports IPH4502 Phase 1 Data Across 76 Patients: Maximum Tolerated Dose 3.6 Mg/Kg Q3W, Grade 3+ TEAEs In 43.4%, Stomatitis Only Dose-Limiting Toxicity
Olema Reports Selective KAT6A Degraders Potently Inhibit Proliferation In Diverse ER+/HER2- Breast Cancer Models, Active In ESR1-Mutant And Wild-Type, Well-Tolerated